CD19 and plasma cell myeloma: We first tested some markers that are commonly used to characterize myeloma cell clones, including markers that could distinguish between true HMCLs and Epstein-Barr virus positive lymphoblastoid cell lines, such as CD19, CD20 and CD1177.